Obesity: A global health crisis in transformation?
By Romain Bodinier, Ph. D, Healthcare Strategies Research at AtonRâ. The over 2000% increase in the prescription of GLP-1 (glucagon-like-peptide-1) molecules since 2019 from Novo Nordisk and Eli Lilly has significantly impacted the investment cases in many MedTech and Biotech companies,